| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |